Effect of Fucoidan on the Mitochondrial Membrane Potential (ΔΨm) of Leukocytes from Patients with Active COVID-19 and Subjects That Recovered from SARS-CoV-2 Infection
2022; Multidisciplinary Digital Publishing Institute; Volume: 20; Issue: 2 Linguagem: Inglês
10.3390/md20020099
ISSN1660-3397
AutoresKarina Janice Guadalupe Díaz‐Reséndiz, Carlos Eduardo Covantes‐Rosales, Alma Betsaida Benítez-Trinidad, Migdalia Sarahy Navidad-Murrieta, Francisco Fabián Razura-Carmona, Christian Daniel Carrillo-Cruz, Edwin Jaime Frias-Delgadillo, Daniela Alejandra Pérez-Díaz, Matxil Violeta Díaz-Benavides, Mercedes Zambrano-Soria, Guadalupe Herminia Ventura‐Ramón, Aurelio Romero‐Castro, David Alam-Escamilla, Manuel Iván Girón‐Pérez,
Tópico(s)Vitamin C and Antioxidants Research
ResumoFucoidan is a polysaccharide obtained from marine brown algae, with anti-inflammatory, anti-viral, and immune-enhancing properties, thus, fucoidan may be used as an alternative treatment (complementary to prescribed medical therapy) for COVID-19 recovery. This work aimed to determine the ex-vivo effects of treatment with fucoidan (20 µg/mL) on mitochondrial membrane potential (ΔΨm, using a cationic cyanine dye, 3,3'-dihexyloxacarbocyanine iodide (DiOC
Referência(s)